- Title
- The characteristics of patients with possible transient ischemic attack and minor stroke in the Hunter and Manning Valley regions, Australia (the INSIST Study)
- Creator
- Tomari, Shinya; Magin, Parker; Lasserson, Daniel; Quain, Debbie; Valderas, Jose M.; Dewey, Helen M.; Barber, P. Alan; Spratt, Neil J.; Cadilhac, Dominique A.; Feigin, Valery L.; Rothwell, Peter M.; Zareie, Hossein; Garcia-Esperon, Carlos; Davey, Andrew; Najib, Nashwa; Sales, Milton; Levi, Christopher R.
- Relation
- NHMRC.1027794 http://purl.org/au-research/grants/nhmrc/1027794
- Relation
- Frontiers in Neurology Vol. 11, Issue 15 May 2020, no. 383
- Publisher Link
- http://dx.doi.org/10.3389/fneur.2020.00383
- Publisher
- Frontiers Research Foundation
- Resource Type
- journal article
- Date
- 2020
- Description
- Background: Transient ischemic attack (TIA) and minor stroke (TIAMS) are risk factors for stroke recurrence. Some TIAMS may be preventable by appropriate primary prevention. We aimed to recruit “possible-TIAMS” patients in the INternational comparison of Systems of care and patient outcomes In minor Stroke and TIA (INSIST) study. Methods: A prospective inception cohort study performed across 16 Hunter–Manning region, Australia, general practices in the catchment of one secondary-care acute neurovascular clinic. Possible-TIAMS patients were recruited from August 2012 to August 2016. We describe the baseline demographics, risk factors and pre-event medications of participating patients. Results: There were 613 participants (mean age; 69 ± 12 years, 335 women), and 604 (99%) were Caucasian. Hypertension was the most common risk factor (69%) followed by hyperlipidemia (52%), diabetes mellitus (17%), atrial fibrillation (AF) (17%), prior TIA (13%) or stroke (10%). Eighty-nine (36%) of the 249 participants taking antiplatelet therapy had no known history of cardiovascular morbidity. Of 102 participants with known AF, 91 (89%) had a CHA2DS2-VASc score ≥ 2 but only 47 (46%) were taking anticoagulation therapy. Among 304 participants taking an antiplatelet or anticoagulant agent, 30 (10%) had stopped taking these in the month prior to the index event. Conclusion: This study provides the first contemporary data on TIAMS or TIAMS-mimics in Australia. Community and health provider education is required to address the under-use of anticoagulation therapy in patients with known AF, possibly inappropriate use of antiplatelet therapy and possibly inappropriate discontinuation of antiplatelet or anticoagulation therapy.
- Subject
- transient ischemic attack; minor stroke; stroke-mimic syndrome; atrial fibrillation; anticoagulation therapy; SDG 3; Sustainable Development Goals
- Identifier
- http://hdl.handle.net/1959.13/1434852
- Identifier
- uon:39528
- Identifier
- ISSN:1664-2295
- Language
- eng
- Reviewed
- Hits: 1772
- Visitors: 1755
- Downloads: 2
Collections
Goal 3: Good Health and Well-Being
| Thumbnail | File | Description | Size | Format |
|---|